Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Moodys
Johnson and Johnson
Harvard Business School
McKinsey

Last Updated: October 21, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Uridine-5'-Diphosphate

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Uridine-5'-Diphosphate: Sponsors, patents, clinical trial progress

Uridine-5'-Diphosphate is an investigational drug.

There have been 31 clinical trials for Uridine-5'-Diphosphate. The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2018.

The most common disease conditions in clinical trials are Depression, Bipolar Disorder, and HIV Infections. The leading clinical trial sponsors are National Cancer Institute (NCI), University Medicine Greifswald, and Repligen Corporation.

There are ten US patents protecting this investigational drug and five hundred and five international patents.

Recent Clinical Trials for Uridine-5'-Diphosphate
TitleSponsorPhase
Clinical Utility of Pharmacogenomics of Psychotropic MedicationsOregon Health and Science UniversityPhase 4
Citicoline Concentration in Human VitreousFondazione G.B. Bietti, IRCCSN/A
Citicoline Concentration in Human VitreousIstituto di Ricerca Neuroftalmologia S.r.l.N/A

See all Uridine-5'-Diphosphate clinical trials

Clinical Trial Summary for Uridine-5'-Diphosphate

Top disease conditions for Uridine-5'-Diphosphate
Top clinical trial sponsors for Uridine-5'-Diphosphate

See all Uridine-5'-Diphosphate clinical trials

US Patents for Uridine-5'-Diphosphate

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Uridine-5'-Diphosphate   Start Trial Compositions containing pufa and/or uridine and methods of use thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGIES (Cambridge, MA)   Start Trial
Uridine-5'-Diphosphate   Start Trial Process for purifying nucleoside-5'-diphosphates Du Pont Merck Pharmaceutical Company (Wilmington, DE)   Start Trial
Uridine-5'-Diphosphate   Start Trial Process for producing carbohydrates using .beta. 1,3-N-acetyl-glucosaminyltransferase Kyowa Hakko Kogyo Co., Ltd. (Tokyo, JP)   Start Trial
Uridine-5'-Diphosphate   Start Trial Joint lubrication with P2Y purinergic receptor agonists Inspire Pharmaceuticals, Inc. (Durham, NC)   Start Trial
Uridine-5'-Diphosphate   Start Trial Polypeptide Kyowa Hakko Kogyo Co., Ltd. (Tokyo, JP)   Start Trial
Uridine-5'-Diphosphate   Start Trial Galactosyl nucleotide sugars Neose Technologies, Inc. (Horsham, PA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Uridine-5'-Diphosphate

Drugname Country Document Number Estimated Expiration Related US Patent
Uridine-5'-Diphosphate Australia 2006251562 2025-05-23   Start Trial
Uridine-5'-Diphosphate Australia 2006251569 2025-05-23   Start Trial
Uridine-5'-Diphosphate Brazil PI0613274 2025-05-23   Start Trial
Uridine-5'-Diphosphate Brazil PI0613303 2025-05-23   Start Trial
Uridine-5'-Diphosphate Canada 2645645 2025-05-23   Start Trial
Uridine-5'-Diphosphate Canada 2645647 2025-05-23   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Baxter
Colorcon
Harvard Business School
Johnson and Johnson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.